Literature DB >> 21134341

Differences in glycemic control and survival predict higher ESRD rates in diabetic First Nations adults.

Roland F Dyck1, Nirmal Sidhu, Helena Klomp, Paul J Cascagnette, Gary F Teare.   

Abstract

PURPOSE: Diabetic First Nations people (FN) have higher ESRD rates than other Canadians but the reasons remain unclear. We sought to better understand this disparity by comparing demographic, laboratory and survival features of diabetic FN and other Saskatchewan residents (OSK) by renal function stage.
METHODS: Prevalent diabetes cases in 2005/06 were identified in Saskatchewan's two largest health regions using administrative databases, and linked with centralized laboratory tests. They were sub-divided into five stages of renal function using estimated glomerular filtration rates (eGFR) that were determined in 992 of 2,321 FN (42.7%) and 14,054 of 21,886 OSK (64.2%). Age, sex, urine microalbumin (MA), glycosylated hemoglobin (A1C), low density lipoprotein cholesterol (LDL-C) and two year mortality risk was compared for all subjects.
RESULTS: Diabetic FN were younger (mean age 52.7 vs. 64.2, p < 0.0001), more likely to be female (59.6% vs.45.4%, p < 0.001), had increased MA (56.6% vs. 48.4%, p < 0.0001) and displayed higher mean A1C levels (8.16% vs.7.36%, p < 0.0001) than OSK. Despite a larger proportion having eGFR's > 60 ml/min (87.0% vs.77.3%, p < 0.001), FN were also more likely to have ESRD (2.3% vs.0.8%, p < 0.001). Although FN with eGFR's > 30 ml/min experienced higher age/sex adjusted mortality risk than OSK, the trends for both adjusted and unadjusted mortality risks for those with advanced pre-ESRD renal failure were lower for FN than for OSK.
CONCLUSIONS: Elevated rates of ESRD experienced by FN with diabetes are related to poorer glycemic control at all levels of renal function, and lower age-related mortality at advanced stages of chronic kidney disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21134341     DOI: 10.25011/cim.v33i6.14590

Source DB:  PubMed          Journal:  Clin Invest Med        ISSN: 0147-958X            Impact factor:   0.825


  6 in total

1.  Quality of care for First Nations and non-First Nations People with diabetes.

Authors:  Vinay Deved; Nathalie Jette; Hude Quan; Marcello Tonelli; Braden Manns; Andrea Soo; Cheryl Barnabe; Brenda R Hemmelgarn
Journal:  Clin J Am Soc Nephrol       Date:  2013-02-28       Impact factor: 8.237

2.  Differential mortality and the excess burden of end-stage renal disease among First Nations people with diabetes mellitus: a competing-risks analysis.

Authors:  Ying Jiang; Nathaniel Osgood; Hyun-Ja Lim; Mary Rose Stang; Roland Dyck
Journal:  CMAJ       Date:  2013-12-02       Impact factor: 8.262

3.  Prevalence, determinants and co-morbidities of chronic kidney disease among First Nations adults with diabetes: results from the CIRCLE study.

Authors:  Roland F Dyck; Mariam Naqshbandi Hayward; Stewart B Harris
Journal:  BMC Nephrol       Date:  2012-07-09       Impact factor: 2.388

4.  Projecting prevalence, costs and evaluating simulated interventions for diabetic end stage renal disease in a Canadian population of aboriginal and non-aboriginal people: an agent based approach.

Authors:  Amy Gao; Nathaniel D Osgood; Ying Jiang; Roland F Dyck
Journal:  BMC Nephrol       Date:  2017-09-04       Impact factor: 2.388

5.  Diabetes in pregnancy in associations with perinatal and postneonatal mortality in First Nations and non-Indigenous populations in Quebec, Canada: population-based linked birth cohort study.

Authors:  Lu Chen; Wen-Juan Wang; Nathalie Auger; Lin Xiao; Jill Torrie; Nancy Gros-Louis McHugh; Zhong-Cheng Luo
Journal:  BMJ Open       Date:  2019-04-15       Impact factor: 2.692

6.  Healthy food prescription incentive programme for adults with type 2 diabetes who are experiencing food insecurity: protocol for a randomised controlled trial, modelling and implementation studies.

Authors:  Dana Lee Olstad; Reed Beall; Eldon Spackman; Sharlette Dunn; Lorraine L Lipscombe; Kienan Williams; Richard Oster; Sara Scott; Gabrielle L Zimmermann; Kerry A McBrien; Kieran J D Steer; Catherine B Chan; Sheila Tyminski; Seth Berkowitz; Alun L Edwards; Terry Saunders-Smith; Saania Tariq; Naomi Popeski; Laura White; Tyler Williamson; Mary L'Abbé; Kim D Raine; Sara Nejatinamini; Aruba Naser; Carlota Basualdo-Hammond; Colleen Norris; Petra O'Connell; Judy Seidel; Richard Lewanczuk; Jason Cabaj; David J T Campbell
Journal:  BMJ Open       Date:  2022-02-15       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.